Comprehensive magnetic resonance characteristics of carbon-encapsulated iron nanoparticles: a new frontier for the core-shell–type contrast agents
Source abstract
Abstract
Abstract The development of carbon-encapsulated iron nanoparticles (CEINS) is of considerable interest in many areas of cancer nanotechnology, ranging from basic tumor biology to early detection and treatment of cancer. To meet these challenges, the present study was undertaken to determine the magnetic and relaxometric performance of CEINS used as a new contrast agent for magnetic resonance imaging (MRI) in preclinical phantom models. CEIN samples were synthesized using a carbon arc discharge route, and the as-synthesized nanoparticles were purified and functionalized with surface acidic groups. The presence of various Fe-bearing metallic phases reflecting the net magnetic properties of CEINS was characterized by powder X-ray diffraction (XRD), thermogravimetry (TGA), and vibrating sample magnetometry. The morphological and surface chemistry features were characterized by electron microscopy (transmission electron microscopy [TEM] and scanning electron microscopy [SEM]), Raman spectroscopy, and Fourier transform-infrared (FT-IR) spectroscopy. The textural properties of CEINS, including porosity, surface total charge density, and zeta potentials, were also measured. The as-synthesized different CEIN samples were finally examined as a potent MRI contrast drug candidate. Magnetic resonance relaxation measurements were performed in bovine gelatin-based phantom models by using a 1.5-T MRI scanner equipped with a standard radiofrequency “birdcage” type head coil. To obtain data, T1- and T2-weighted MR images were acquired using the inversion recovery spin echo (SE) and the SE protocol with multiple time of echo (TE), respectively. Chemical characterization showed similarity in morphology and textural properties between as-synthesized CEINS, purified CEINS, and CEINS functionalized with acidic groups. The as-synthesized CEINS had significantly higher Fe content and higher saturation magnetization. The analysis of the relaxometric properties of CEINS revealed that all the CEIN samples decreased T2 relaxation times on the T2-weighted images. The relaxation rate (1/T2) showed some differences between the as-synthesized, purified, and surface-functionalized CEINS containing surface carboxylic groups. Both the as-synthesized and purified CEINS slightly decreased the T1 relaxation times, which was evident through increase in the relaxation rates (1/T1). This study concludes that CEINS may represent a novel “core-shell”–type negative contrast drug candidate for MRI. It should be emphasized that all the studied CEIN samples have acceptable r2 relaxivities at the field strength of 1.5 T where most of the MRI systems operate in clinical radiology.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Characterization and Applications of Magnetic Nanoparticles · Nanoparticle-Based Drug Delivery · Advanced MRI Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Ahmad A, Bae H, Rhee I (2018) Highly stable silica-coated manganese ferrite nanoparticles as high-efficacy T2 contrast agents for magnetic resonance imaging. AIP Adv 8:05501910.1063/1.5027898 ↗
2. Atabaev TS, Lee JH, Han DW, Kim HK, Hwang YH (2015) Fabrication of carbon coated gadolinia particles for dual-mode magnetic resonance and fluorescence imaging. J Adv Ceram 4(2):118–12210.1007/s40145-015-0139-z ↗
3. Bae H, Ahmad T, Rhee I, Chang Y, Jin SU, Hong S (2012) Carbon-coated iron oxide nanoparticles as contrast agents in magnetic resonance imaging. Nanoscale Res Lett 7:4410.1186/1556-276X-7-44 ↗
4. Bamburowicz-Klimkowska M, Poplawska M, Grudzinski IP (2019) Nancomposites as biomolecules delivery agents in nanomedicine. J Nanobiotechnol 17:4810.1186/s12951-019-0479-x ↗
5. Boehm HP (1994) Some aspects of the surface chemistry of carbon blacks and other carbons. Carbon 32(5):759–76910.1016/0008-6223(94)90031-0 ↗
6. Borysiuk J, GrabiasA SJ, Bystrzejewski M, Twardowski A, Lange H (2008) Structure and magnetic properties of carbon encapsulated Fe nanoparticles obtained by arc plasma and combustion synthesis. Carbon 46:1693–170110.1016/j.carbon.2008.07.011 ↗
7. Bystrzejewski M, Huczko A, Lange H (2005) Arc plasma route to carbon-encapsulated magnetic nanoparticles for biomedical applications. Sens Actuators B-Chem 109:81–8510.1016/j.snb.2005.03.029 ↗
8. Bystrzejewski M, Cudziło S, Huczko A, Lange H (2006) Thermal stability of carbon-encapsulated Fe–Nd–B nanoparticles. J Alloys Compd 423:74–7610.1016/j.jallcom.2005.12.047 ↗
9. Bystrzejewski M, Cudziło S, Huczko A, Lange H, Soucy G, Cota-Sanchez G, Kaszuwara W (2007) Carbon encapsulated magnetic nanoparticles for biomedical applications: thermal stability studies. Biomol Eng 24(5):555–55810.1016/j.bioeng.2007.08.006 ↗
10. Bystrzejewski M, Karoly Z, Szepvolgyi J, Huczko A, Lange H (2011) Continuous synthesis of controlled size carbon-encapsulated iron nanoparticles. Mater Res Bull 46:2408–241710.1016/j.materresbull.2011.08.047 ↗
11. Bystrzejewski M, Łabędź O, Kaszuwara W, Huczko A, Lange H (2013) Controlling the diameter and magnetic properties of carbon-encapsulated iron nanoparticles produced by carbon arc discharge. Powder Technol 246:7–1510.1016/j.powtec.2013.04.052 ↗
12. Caravan P, Greenfield MT, JWM B (2001) Molecular factors that determine curie spin relaxation in dysprosium complexes. Magn Reson Med 46:917–92210.1002/mrm.1277 ↗
13. Caravan P, Farrar CT, Frullano L, Uppal R (2009) Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents. Contrast Media Mol Imaging 4:89–10010.1002/cmmi.267 ↗
14. Chung J, Yu JS, Kim DJ, Chung JJ, Kim JH, Kim KW (2011) Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI. Magn Reson Imaging 29:1235–124310.1016/j.mri.2011.07.025 ↗
15. Dayie KT, Wagner G, Lefèvre JF (1996) Theory and practice of nuclear spin relaxation in proteins. Annu Rev Phys Chem 47:243–28210.1146/annurev.physchem.47.1.243 ↗
16. Di Marco M, Sadun C, Port M, Guilbert I, Couvreur P, Dubernet C (2007) Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents. Int J Nanomedicine 2(4):609–622
17. Ebert S, Bannwarth MB, Musyanovych A, Landfester K, Münnemann K (2015) How morphology influences relaxivity – comparative study of superparamagnetic iron oxide–polymer hybrid nanostructures. Contrast Media Mol Imaging 10:456–46410.1002/cmmi.1648 ↗
18. El-Gendy AA, EMM I, Khavrus VO, Krupskaya Y, Hampel S, Leonhardt A, Klingeler BR (2009) The synthesis of carbon coated Fe, Co and Ni nanoparticles and an examination of their magnetic properties. Carbon 47(12):2821–282810.1016/j.carbon.2009.06.025 ↗
19. Grudzinski IP, Bystrzejewski M, Cywinska MA, Kosmider A, Poplawska M, Cieszanowski A, Ostrowska A (2013) Cytotoxicity evaluation of carbon-encapsulated iron nanoparticles in melanoma cells and dermal fibroblasts. J Nanopart Res 15:183510.1007/s11051-013-1835-7 ↗
20. Jarrett BR, Frendo M, Vogan J, Louie AY (2007) Size controlled synthesis of dextran sulfate coated iron oxide nanoparticles for magnetic resonance imaging. Nanotechnology 18:03560310.1088/0957-4484/18/3/035603 ↗
21. Jasmin de Souza GT, Louzada RA, Rosado-de-Castro PH, Mendez-Otero R, Campos de Carvalho AC (2017) Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations. Int J Nanomedicine 12:779–79310.2147/IJN.S126530 ↗
22. Joos A, Löwa N, Wiekhorst F, Gleich B, Haase A (2017) Size-dependent MR relaxivities of magnetic nanoparticles. J Magn Magn Mater 427:122–12610.1016/j.jmmm.2016.11.021 ↗
23. Kasprzak A, Popławska M, Bystrzejewski M, Łabędź O, Grudzinski IP (2015) Conjugation of polyethylenimine and its derivatives to carbon-encapsulated iron nanoparticles. RCS Adv 5:85556
24. Kasprzak A, Poplawska M, Bystrzejewski M, Grudzinski IP (2016) Sulfhydrylated graphene-encapsulated iron nanoparticles directly aminated with polyethylenimine: a novel magnetic nanoplatform for bioconjugation of gamma globulins and polyclonal antibodies. J Mater Chem B 4:5593–560710.1039/C6TB00838K ↗
25. Khramtsov P, Kropaneva M, Byzov I, Minin A, Mysik A, Timganova V, Bochkova M, Uimin M, Zamorina S, Yermakov A, Rayev M (2019) Conjugation of carbon coated-iron nanoparticles with biomolecules for NMR-based assay. Colloids Surf B: Biointerfaces 176:256–26410.1016/j.colsurfb.2019.01.009 ↗
26. Knobloch G, Colgan T, Wiens CN, Wang X, Schubert S, Hernando D, Sharma SD, Reeder S (2018) Relaxivity of ferumoxytol at 1.5T and 3.0 T. Investig Radiol 53(5):257–26310.1097/RLI.0000000000000434 ↗
27. Krishnan KM (2010) Biomedical nanomagnetics: a spin through possibilities in imaging, diagnostics, and therapy. IEEE Trans Magn 46(7):2523–255810.1109/TMAG.2010.2046907 ↗
28. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations and biological applications. Chem Rev 108(6):2064–211010.1021/cr068445e ↗
29. LE LC, Nitin N, Zurkiya O, Caruntu D, O’Connor CJ, Hu X, Bao G (2017) Coating thickness of magnetic iron oxide nanoparticles affects r2 relaxivity. J Magn Reson Imaging 26:1634–1641
30. Lee KJ, An JH, Chun JR, Chung KH, Park WY, Shin JS, Kim DH, Bahk YY (2013) In vitro analysis of the anti-cancer activity of mitoxantrone loaded on magnetic nanoparticles. J Biomed Nanotechnol 9(6):1071–107510.1166/jbn.2013.1530 ↗
31. Lee HJ, Sanetuntikul J, Choi ES, Lee BR, Kim JH, Kim E, Shanmugam S (2014) Photothermal cancer therapy using graphitic carbon-coated magnetic particles prepared by one-pot synthesis. Int J Nanomedicine 10:271–282
32. Maurea S, Mainenti PP, Tambasco A, Imbriaco M, Mollica C, Laccetti E, Camera L, Liuzzi R, Salvatore M (2014) Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media. Quant Imaging Med Surg 4:181–189
33. Pankhurst QA, NKT T, Jones SK, Dobson J (2009) Progress in applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 42:22400110.1088/0022-3727/42/22/224001 ↗
34. Park JH, Jung J, Subramaniam P, Shah BP, Kim C, Lee JK, Cho JH, Ch L, Lee KB (2011) Graphite-coated magnetic nanoparticles as multimodal imaging probes and cooperative therapeutic agents for tumor cells. Small 7(12):1647–165210.1002/smll.201100012 ↗
35. Poplawska M, Bystrejewski M, Grudzinski IP, Cywinska MA, Ostapko J, Cieszanowski A (2014) Immobilization of gamma globulins and polyclonal antibodies of class IgG onto carbon-encapsulated iron nanoparticles functionalized with various surface linkers. Carbon 74:180–19410.1016/j.carbon.2014.03.022 ↗
36. Roch A, Muller RN, Gillis P (1999) Theory of proton relaxation induced by superparamagnetic particles. J Chem Phys 110(11):5403–541110.1063/1.478435 ↗
37. Roch A, Gossuin Y, Muller RN, Gillis P (2005) Superparamagnetic colloid suspensions: water magnetic relaxation and clustering. J Magn Magn Mater 293:532–53910.1016/j.jmmm.2005.01.070 ↗
38. Shubayev VJ, Pisanic TR, Jin S (2009) Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 61(6):467–47710.1016/j.addr.2009.03.007 ↗
39. Sun C, JSH L, Znang M (2008) Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 60(11):1252–126510.1016/j.addr.2008.03.018 ↗
40. Ta HT, Li Z, Wu Y, Cowin G, Zhang S, Yago A, Whittaker AK, Xu ZP (2017) Effects of magnetic field strength and particle aggregation on relaxivity of ultra-small dual contrast iron oxide nanoparticles. Mater Res Express 4(11):11610510.1088/2053-1591/aa96e3 ↗
41. Tartj P (2006) Nanomagnetics from foundamental physics to biomedicine. Curr Nanosci 2:43–5310.2174/157341306775473818 ↗
42. Vallabani NVS, Singh S, Karakoti AS (2019) Magnetic nanoparticles: current trends and future aspects in diagnostics and nanomedicine. Curr Drug Metab 20(6):457–47210.2174/1389200220666181122124458 ↗
43. Vasanawala SS, Nguyen KL, Hope MD, Bridges MD, Hope TA, Reeder SB, Bashir MR (2016) Safety and technique of ferumoxytol administration for MRI. Magn Reson Med 75:2107–211110.1002/mrm.26151 ↗
44. Wang YXJ (2011) Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med Surg 1(1):35–40
45. Wang YXJ, Idée JM (2017) A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging. Quant Imaging Med Surg 7(1):88–12210.21037/qims.2017.02.09 ↗
46. Wang YXJ, Hussain SM, Krestin GP (2001) Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 11(11):2319–233110.1007/s003300100908 ↗
47. Zhang W, Liu L, Chen H, Hu K, Delahunty I, Gao S, Xie J (2018) Surface impact on nanoparticle-based magnetic resonance imaging contrast agents. Theranostics 8(9):2521–254810.7150/thno.23789 ↗